ABSTRACT Chylous ascites is rare and results in accumulation of lymph in the abdominal cavity, due to several mechanisms. The ascitic liquid is milky because of the high concentration of triglycerides (>200 mg/dl). The higher incidence compared to the past is explained by increased survival of patients with cancer and more aggressive surgery. We describe the case of an 87-year-old man admitted to the geriatric ward due to general oedema, chylous ascites and loss of weight, explained by mantle cell lymphoma.
INTRODUCTION
Chylous ascites is a relatively rare form of ascites resulting in the accumulation of lymph in the abdominal cavity. It is characterized by a milky ascitic liquid with an elevated concentration of triglycerides (>200 mg/dl) [1] . Although there have been no recent large epidemiological studies, it is generally believed that its incidence has increased due to the longer survival of patients with cancer and more aggressive abdominal and cardiothoracic interventions. The main pathophysiological mechanisms postulated for this condition are: (a) obstruction of the flow of lymph caused by external pressure leading to leakage from dilated subserosal lymphatic channels into the peritoneal cavity; (b) lymph exuding through the walls of dilated retroperitoneal vessels without valves, which leak fluid through a fistula into the peritoneal cavity, as in congenital lymphangiectasia; and (c) traumatic obstruction of the thoracic duct [2] . We describe a case of lymphoproliferative disease presenting as chylous ascites.
CASE REPORT An 87-year-old man presented with abdominal distension, peripheral oedema and constitutional symptoms of fatigue, anorexia and involuntary weight loss (12.7%). His medical history was positive for hypertension and alcohol consumption of 36 g per day for the last 40 years. There was a positive family history of gastrointestinal cancer. On physical examination, the patient had obvious ascites (grade III) and lower extremity oedema. Vital signs were normal. There was no jaundice or scleral icterus and also no signs of chronic liver disease, palmar erythema, enlarged parotids or gynecomastia. The abdomen was distended with bulging flanks, a fluid wave, shifting dullness and signs of hepatofugal collateral circulation. No abdominal organomegaly was detected. Cardiovascular and pulmonary examinations were normal. Pitting oedema was present in both legs up to the thighs. Two enlarged axillary lymph nodes were also detected. Initial investigation revealed a widened mediastinum on chest X-ray (Fig. 1) 2). Viral serologies (HIV, HCV, HBV) were also negative. In the urinalysis no pathological alteration was found, except for low grade proteinuria. Serum electroimmunofixation was positive for IgM lambda. Subsequent investigation with computerized tomography (CT) revealed multiple thoracic and abdominal lymphadenopathies forming large conglomerates, the largest abdominal mass having a diameter of 20 cm (Fig. 2) . The patient began oral furosemide 40 mg and spironolactone 100 mg with ascites volume reduction and better symptom control. Excisional biopsy of the axillary adenopathy revealed mantle cell lymphoma with a diffuse architectural pattern, classic type with a proliferative index of 20% (Fig. 3) . Bone marrow and gastrointestinal involvement was not investigated since treatment would not be effective. Stage III/IV mantle cell non-Hodgkin lymphoma was diagnosed and after discussing the goals of treatment, palliative chemotherapy according the PEPC protocol (prednisolone 20 mg once a day (OD), cyclophosphamide 50 mg OD, etoposide 50 mg OD and procarbazine 50 mg OD). The patient died from pneumonia 1 month after beginning treatment. 
